{"id":"https://openalex.org/W1940368958","doi":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","title":"Multicenter Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab in the Treatment of Recurrent Malignant Glioma (S43.005)","display_name":"Multicenter Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab in the Treatment of Recurrent Malignant Glioma (S43.005)","publication_year":2015,"publication_date":"2015-04-06","ids":{"openalex":"https://openalex.org/W1940368958","doi":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","mag":"1940368958"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.84.14_supplement.s43.005","doi":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041092173","display_name":"Elizabeth C. Neil","orcid":"https://orcid.org/0009-0001-6830-5308","observed_orcids":["https://orcid.org/0009-0001-6830-5308"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Neil","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center New York NY United States","6Memorial Sloan-Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"6Memorial Sloan-Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052248018","display_name":"Jennifer Leigh Clarke","orcid":"https://orcid.org/0000-0002-8054-7342","observed_orcids":["https://orcid.org/0000-0002-8054-7342"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Clarke","raw_affiliation_strings":["UCSF San Francisco CA United States","8UCSF San Francisco CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF San Francisco CA United States","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"8UCSF San Francisco CA United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012372987","display_name":"Kathryn P. Beal","orcid":"https://orcid.org/0000-0003-0989-6723","observed_orcids":["https://orcid.org/0000-0003-0989-6723"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn Beal","raw_affiliation_strings":["Radiation Oncology Memorial Sloan Kettering Cancer Center New York NY United States","4Radiation Oncology Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"4Radiation Oncology Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109911992","display_name":"Phillip H. Gutin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phillip Gutin","raw_affiliation_strings":["New York NY United States","1New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York NY United States","institution_ids":[]},{"raw_affiliation_string":"1New York NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109374295","display_name":"Igor J. Barani","orcid":"https://orcid.org/0000-0002-8256-1906","observed_orcids":["https://orcid.org/0000-0002-8256-1906"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barani Igor","raw_affiliation_strings":["Radiation Oncology University of California, San Francisco San Francisco CA United States","9Radiation Oncology University of California, San Francisco San Francisco CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology University of California, San Francisco San Francisco CA United States","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"9Radiation Oncology University of California, San Francisco San Francisco CA United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042155392","display_name":"Thomas Joseph Kaley","orcid":"https://orcid.org/0000-0002-2540-8518","observed_orcids":["https://orcid.org/0000-0002-2540-8518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Kaley","raw_affiliation_strings":["New York NY United States","1New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York NY United States","institution_ids":[]},{"raw_affiliation_string":"1New York NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Lassman","raw_affiliation_strings":["Columbia University Medical Center New York NY United States","2Columbia University Medical Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center New York NY United States","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"2Columbia University Medical Center New York NY United States","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015897568","display_name":"Malbora Perezic-Mustafa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malbora Perezic-Mustafa","raw_affiliation_strings":["Neurology Memorial Sloan Kettering Cancer Center New York NY United States","3Neurology Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"3Neurology Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012613674","display_name":"Robert J. Young","orcid":"https://orcid.org/0000-0001-7003-3017","observed_orcids":["https://orcid.org/0000-0001-7003-3017"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Young","raw_affiliation_strings":["Radiology Memorial Sloan Kettering Cancer Center New York NY United States","5Radiology Memorial SLoan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiology Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"5Radiology Memorial SLoan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033270808","display_name":"Antonio M. P. Omuro","orcid":"https://orcid.org/0000-0003-4299-3664","observed_orcids":["https://orcid.org/0000-0003-4299-3664","https://orcid.org/0000-0002-7007-2224"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Omuro","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center New York NY United States","6Memorial Sloan-Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"6Memorial Sloan-Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.04531882,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"14_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-malignant-glioma","display_name":"recurrent malignant glioma","score":0.921999990940094},{"id":"https://openalex.org/keywords/hypofractionated-stereotactic-radiotherapy","display_name":"hypofractionated stereotactic radiotherapy","score":0.9660000205039978},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.746999979019165},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/reirradiation","display_name":"re-irradiation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.593999981880188},{"id":"https://openalex.org/keywords/radiation-necrosis","display_name":"radiation necrosis","score":0.6740000247955322},{"id":"https://openalex.org/keywords/vascular-permeability","display_name":"vascular permeability","score":0.578000009059906},{"id":"https://openalex.org/keywords/phase-i-trial-design","display_name":"phase I trial design","score":0.42800000309944153},{"id":"https://openalex.org/keywords/3-3-design","display_name":"3+3 design","score":0.6629999876022339},{"id":"https://openalex.org/keywords/neurological-deterioration","display_name":"neurological deterioration","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8638912439346313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8337852954864502},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.682893693447113},{"id":"https://openalex.org/C2992393070","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Stereotactic radiotherapy","level":4,"score":0.5655258297920227},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4630586802959442},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35448503494262695},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.34717023372650146},{"id":"https://openalex.org/C2780387249","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Radiosurgery","level":3,"score":0.30999836325645447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23991790413856506},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13285565376281738},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.05597451329231262}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.84.14_supplement.s43.005","doi":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.s43.005","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2732147664","https://openalex.org/W2137686302","https://openalex.org/W4415170345","https://openalex.org/W2073649720","https://openalex.org/W2062360412","https://openalex.org/W3101467937","https://openalex.org/W2767742536","https://openalex.org/W2193257912","https://openalex.org/W4248130349","https://openalex.org/W2144590611"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2],"a":[3,36,87],"phase":[4,65],"I":[5,66],"study":[6,67],"of":[7,91,94,156,166,172,178,182,197],"hypofractionated":[8],"stereotactic":[9],"radiotherapy":[10,31,71,271],"(HFSRT)":[11],"and":[12,73,111,152,176,236,256,270,278,290],"bevacizumab":[13,103,206,253],"in":[14,39,46,100,119,238,248,263,273],"recurrent":[15,40,79],"malignant":[16],"gliomas":[17],"(MG).":[18],"BACKGROUND:":[19],"Bevacizumab":[20],"is":[21,231,276],"associated":[22],"with":[23,78,163,252],"decreased":[24],"vascular":[25],"permeability":[26],"allowing":[27],"for":[28,233],"more":[29],"aggressive":[30],"schedules.":[32],"We":[33],"previously":[34],"investigated":[35],"re-irradiation":[37],"approach":[38],"MG":[41,80],"utilizing":[42],"HFSRT":[43,113,195],"(30Gy":[44],"delivered":[45,122,247,262],"5":[47,264],"fractions),":[48],"which":[49],"achieved":[50],"interesting":[51],"results":[52],"(median":[53],"overall":[54],"survival":[55],"[OS]:":[56],"12.5m,":[57],"without":[58],"radionecrosis).":[59],"Recurrences":[60],"remained":[61],"local,":[62],"prompting":[63],"this":[64],"attempting":[68],"to":[69,142,150,224,258],"escalate":[70],"doses":[72,118],"hypofractionation.":[74],"METHODS:":[75],"Bevacizumab-na\u00efve":[76],"patients":[77,158,185,191,235,239,275],"(tumor":[81],"volume":[82],"<40cc)":[83],"were":[84,135,161],"enrolled":[85],"following":[86],"3+3":[88],"design,":[89],"regardless":[90],"the":[92,143,188,212,259,291],"number":[93],"previous":[95,144,180,260],"recurrences.":[96],"Treatment":[97],"was":[98,104,114],"given":[99,105,115],"28-day":[101],"cycles;":[102],"at":[106,116,138,211],"10mg/kg":[107],"on":[108,123],"days":[109],"1":[110,203],"14;":[112],"escalating":[117],"3":[120,179,190,218,249],"fractions":[121,146,250],"alternate":[124],"days,":[125],"starting":[126,137],"cycle":[127,202],"2":[128],"day":[129],"7.":[130],"RESULTS:":[131],"Three":[132],"dose":[133,214,285],"levels":[134],"evaluated,":[136],"9Gy":[139],"(biologically":[140],"equivalent":[141],"30Gy/5":[145],"regimen),":[147],"then":[148],"escalated":[149],"10":[151],"11Gy.":[153],"A":[154],"total":[155],"12":[157],"(GBM:":[159],"N=9)":[160],"enrolled,":[162],"median":[164,170,177],"age":[165],"61":[167],"(range":[168,174],"47-71),":[169],"KPS":[171],"90":[173],"80-100),":[175],"lines":[181],"treatment.":[183],"Nine":[184],"received":[186],"HFSRT;":[187],"other":[189],"did":[192],"not":[193],"receive":[194],"because":[196],"increased":[198],"tumor":[199,227,268],"size":[200],"during":[201],"(N=2)":[204],"or":[205],"toxicity":[207],"(N=1).":[208],"One":[209],"patient":[210],"11Gy":[213,292],"level":[215],"developed":[216],"grade":[217],"fatigue/neurologic":[219],"deterioration":[220],"deemed":[221],"possibly":[222],"related":[223],"radiotherapy,":[225],"versus":[226],"progression.":[228],"Median":[229],"OS":[230],"12m":[232],"all":[234],"13m":[237],"receiving":[240],"HFSRT.":[241],"CONCLUSIONS:":[242],"Results":[243],"suggest":[244],"hypofractionation":[245,261],"schedules":[246],"combined":[251],"are":[254,282],"feasible":[255],"comparable":[257],"fractions.":[265],"Differentiating":[266],"between":[267],"progression":[269],"effects":[272],"these":[274],"challenging":[277],"novel":[279],"neuroimaging":[280],"tools":[281],"needed.":[283],"Further":[284],"escalation":[286],"may":[287],"be":[288,295],"warranted":[289],"cohort":[293],"will":[294],"expanded.":[296]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}